Call Us
+919016820285
Contact Us For Help
Products
Home » Products » Anesthesia Medicines » Sojourn, Ultane, Sevorane, Sevotroy

Sojourn, Ultane, Sevorane, Sevotroy

Sojourn, Ultane, Sevorane, Sevotroy
Sojourn, Ultane, Sevorane, Sevotroy
Send Inquiry
Product Code : Sevoflurane
Product Specifications
  • Drug Type
  • Other Types
  • Ingredients
  • Sevoflurane
  • Physical Form
  • Liquid
  • Dosage
  • As Directed By Physician
  • Quantity
  • 50 ml, 250 ml Unit
  • Storage Instructions
  • Store in Cool & Dry Place
Product Description
Sevoflurane, is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.

It is one of the most commonly used volatile anesthetic agents, particularly for outpatient anesthesia, across all ages, as well as in veterinary medicine. Together with desflurane, sevoflurane is replacing isoflurane and halothane in modern anesthesiology. It is often administered in a mixture of nitrous oxide and oxygen.

Sevoflurane "has an excellent safety record", but is under review for potential neurotoxicity, especially relevant to administration in infants and children, and rare reports similar to halothane hepatotoxicity. Sevoflurane is the preferred agent for mask induction due to its lesser irritation to mucous membranes.

Sevoflurane was discovered by Ross Terrel and independently by Bernard M Regan. A detailed report of its development and properties appeared in 1975 in a paper authored by Richard Wallin, Bernard Regan, Martha Napoli and Ivan Stern. It was introduced into clinical practice initially in Japan in 1990 by Maruishi Pharmaceutical Co., Ltd. Osaka, Japan. The rights for sevoflurane worldwide were held by AbbVie. It is now available as a generic drug.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:
Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.

Tags
Sevoflurane Vaporizer Manufacturers India Sevoflurane Vaporizer suppliers India Sevoflurane Vaporizer Exporters India Sevoflurane Vaporizer Wholesalers India Sevoflurane Vaporizer Distributors India Sevoflurane Vaporizer Dropshipper India Sevoflurane Vaporizer Bulk Drugs Suppliers India Buy Sevoflurane Vaporizer Online India Sevoflurane Vaporizer Price Generic Sevoflurane Vaporizer SupplierBuy Generic Sevoflurane Vaporizer Online IndiaSevoflurane Vaporizer Trader India Sevoflurane VaporizerSevotroy

Trade Information
  • FOB Port
  • Hazira / Nhava Sheva
  • Payment Terms
  • Telegraphic Transfer (T/T), Cash Advance (CA)
  • Supply Ability
  • 100000 Per Month
  • Delivery Time
  • 1 Week
  • Sample Available
  • Yes
  • Sample Policy
  • If order is confirmed we will reimburse the sample cost
  • Packaging Details
  • Packing : 50 ml, 250 ml Pack Insert/Leaflet : Yes
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India
  • Certifications
  • WHO-GMP/ GMP/ COA/ As Required By Client

SALVAVIDAS PHARMACEUTICAL PVT. LTD.
X